Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Thus profit is highly sensitive to changes in sales price
Tirzepatide : Clinical studies have shown that participants can lose an average of 15% to 20% of their body weight over 72 weeks
Flashback: Hims & Hers CEO Andrew Dudum told Axios in 2023 that the company viewed weight-loss drugs as an "exciting space" and that "it's not a question of will Hims & Hers have a weight offering it's really just a question of when and how." The intrigue: Hims & Hers can offer the so-called compounded version of the drugs due to their appearance on the FDA's drug shortages list, Bloomberg noted
March 28, 2025 Update: Plaintiffs in the GLP-1 drug litigation formally opposed efforts by drug manufacturers to dismiss most claims in the consolidated master complaint
US$ 25.80
US$ 24.34
US$ 28.07
US$ 29.42
US$ 26.96
US$ 29.80
US$ 25.63
US$ 29.15
